Z-1826-2012 Class I Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-1826-2012 was initiated by Fresenius Medical Care Holdings, Inc. on Mar 29, 2012 and is designated Class I. Reason for recall: Risk of Alkalosis with acetate containing dialysis acid concentrates The recall status is terminated (terminated Jul 20, 2017).

Recall details

Product Type
Devices
Report Date
Jul 4, 2012
Initiation Date
Mar 29, 2012
Termination Date
Jul 20, 2017
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Fresenius NaturaLyte Liquid Acid Concentrate Product Codes: 08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8,08-3201-4,08-3231-1,08-3251-9,08-3301-2,08-4123-1, 08-4223-7, 08-4225-1' 08-4230-2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1,13-3251-9, 13-4123-1' 13-4220-1, 13-4225-1 ' 13-4325-1. For the treatment of acute and chronic renal failure during hemodialysis procedure.

Reason for recall

Risk of Alkalosis with acetate containing dialysis acid concentrates

Distribution pattern

Nationwide Distribution and the country of Guam.

Code information

All lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1826-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1826-2012. Report a data issue: hello@regdatalab.com.